Shionogi & Co., Ltd. is pleased to announce that it has entered into an exclusive licensing agreement with Link Medical Products Pty Ltd, part of Clinigen, the global specialty pharmaceutical services group for the development and commercialization of cefiderocol in Australia and New Zealand.
Shionogi Press Release